Peritendinous adhesion is the main reason of the limitation of limb function. At the process of tendon healing, anti-adhesion membranes can act as a physical barrier but can not inhibit inflammation response and adhesion tissue formation. Some researches confirmed that the nuclear factor kappa B (NF-κB) played a key role in the inflammation and extracellular matrix secretion of cells. SiRNA targeted on NF-κB p65 could significantly reduce the inflammation and tissue hyperplasia. On this basis of previous studies, this project intends to prepare hyaluronic acid(HA)-polylactic acid (PLLA) electrospun fibers with core-shell structure by our previous study of micro gel electrospinning technology, which loaded NF-κB p65 siRNA in HA gel, could be made with good physical barrier and effective slow release of active siRNA. The property of anti-adhesion could be confirmed by testing the sustained-release properties of siRNA in vitro, the effect of membranes on the fibroblasts, and the inhibition of tendon adhesion and inflammation in vivo. Furthermore, the NF-κB p65 inhibition in fibroblasts and adhesion tissue was determined to explore the mechanism of tendon adhesion, this project provides a new treatment for prevention of tendon adhesion and theoretical basis.
肌腱粘连是影响手部外伤后功能恢复的重要原因。在肌腱修复过程中,采用生物材料制成的防粘连膜具有一定的物理阻隔作用,但不能抑制术后的腱周炎症反应和粘连形成。相关研究证实核因子-κB(NF-κB)在细胞炎症及细胞外基质分泌中起着关键性作用,靶向作用于NF-κB p65的siRNA能够明显减轻细胞炎症及组织增生。在此基础之上,本课题拟采用前期研究的微凝胶静电纺丝技术制备具有壳-芯结构的透明质酸-聚乳酸电纺纤维,将NF-κB p65 siRNA负载于透明质酸凝胶内芯中,可望制成既具有良好的物理阻隔作用,又具备缓慢释放活性siRNA性能的防粘连膜。经过检测该膜的siRNA缓释特性,体外观察其对成纤维细胞的作用,体内观察对腱周粘连及炎性反应的抑制作用,明确其防止肌腱粘连的效果。同时,对细胞与粘连组织NF-κB p65抑制水平进行测定,探讨肌腱粘连的机制,本课题为防止肌腱粘连提供新的治疗方法及理论依据。
肌腱粘连是临床难以解决的问题之一,严重影响了患者的肢体功能康复。在肌腱修复过程中,采用生物材料制成的防粘连膜具有一定的物理阻隔作用,但不能抑制术后的腱周炎症反应和粘连形成。小干扰RNA(siRNA)作为一种新型的靶向药物,为相关疾病提供了更为准确的治疗,显示出印象深刻的治疗潜力。相关研究证实核因子-κB(NF-κB)在细胞炎症及细胞外基质分泌中起着关键性作用。在此基础之上,本课题首先利用p65 siRNA作用于体外培养的成纤维细胞,检测其对细胞增殖、凋亡的影响,同时通过对细胞内p65蛋白的活化进行检测,结果发现p65 siRNA通过抑制p65蛋白活化进而抑制成纤维细胞增殖、细胞外基质的分泌,同时抑制了COX-2的表达,然后利用微凝胶静电纺丝技术制备了具有壳-芯结构的负载p65 siRNA的HA-PLLA电纺膜,并对其进行了表征,发现负载p65 siRNA的HA-PLLA电纺膜有较低的亲水性,能够形成平滑、连续的纤维,并且更能持续缓慢地释放p65 siRNA,减少p65 siRNA的突释,释放时间超过30天。体外细胞实验发现负载p65 siRNA的HA-PLLA电纺膜能够将p65 siRNA转染入细胞内并明显抑制细胞增殖,同时,通过抑制细胞内NF-κB p65的表达进而抑制胶原蛋白、炎性因子的表达,暗示了p65下调可能成为治疗肌腱粘连的办法。本课题为防止肌腱粘连提供新的治疗方法及理论依据。
{{i.achievement_title}}
数据更新时间:2023-05-31
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
内点最大化与冗余点控制的小型无人机遥感图像配准
The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects
基于ESO的DGVSCMG双框架伺服系统不匹配 扰动抑制
Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia
负载双介孔硅与P65 siRNA/布洛芬复合纳米粒子的PELA电纺纤维膜 防治肌腱粘连的作用及机制研究
负载塞来昔布的PELA纳米纤维膜防止肌腱粘连的相关机制研究
外层负载ERK2-siRNA的双向组织匹配性纳米纤维膜抑制肌腱粘连组织增生的相关机制研究
控释活性生物分子的氧化凝胶静电纺纤维及抑制肌腱粘连研究